SCHEMBL27893370

SCHEMBL27893370

CCOC(=O)CNc1c([N+](=O)[O-])ccc(Cl)c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.52
THRB P10828 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
MAPT P10636 5/20 0.42
KDM4E B2RXH2 2/20 0.42
BCL6 P41182 1/20 0.41
BCOR Q6W2J9 1/20 0.41
HTT P42858 1/20 0.41
GLA P06280 1/20 0.41
POLB P06746 1/20 0.40
ALDH1A1 P00352 4/20 0.40
NPC1 O15118 1/20 0.39
PKM P14618 1/20 0.39
CRHBP P24387 1/20 0.39
RAB9A P51151 1/20 0.39
CRHR2 Q13324 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GAA P10253 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703710 0.84 LMNA (0.46) LMNATHRBTDP1MAPTPOLB
SCHEMBL3592533 0.82 LMNA (0.57) LMNATDP1MAPTKDM4EGLA
SCHEMBL273112 0.80 LMNA (0.45) LMNATHRBTDP1MAPTKDM4E
SCHEMBL9955398 0.80 LMNA (0.52) LMNAMAPTKDM4EGLAPOLB
Hydrochloric Acid SCHEMBL273187 0.79 LMNA (0.44) LMNATHRBTDP1MAPTKDM4E
SCHEMBL11066636 0.79 TDP1 (0.55) LMNATDP1MAPTALDH1A1L3MBTL1
SCHEMBL27876663 0.79 NLRP3 (0.42) LMNAMAPTKDM4EHTTPOLB
SCHEMBL21631638 0.78 LMNA (0.45) LMNATHRBMAPTKDM4EHTT
SCHEMBL1346377 0.77 LMNA (0.52) LMNAMAPTKDM4EGLAPOLB
SCHEMBL31657581 0.77 LMNA (0.52) LMNATDP1MAPTKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102757434-B Preparation method for industrial amplified production of anagrelide hydrochloride active pharmaceutical ingredient HEILONGJIANG TIMEHOME PHARMACEUTICAL CO LTD 2014-06-04 CN disclosed
CN-102757434-A Preparation method for industrial amplified production of anagrelide hydrochloride active pharmaceutical ingredient HEILONGJIANG TIMEHOME PHARMACEUTICAL CO LTD 2012-10-31 CN disclosed